Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma

In multiple myeloma, novel treatments with proteasome inhibitors (PIs) and immunomodulatory agents (IMiDs) have prolonged survival but the disease remains incurable. At relapse, next-generation sequencing has shown occasional mutations of drug targets but has failed to identify unifying features tha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Ziccheddu, Bachisio, Biancon, Giulia, Bagnoli, Filippo, De Philippis, Chiara, Maura, Francesco, Rustad, Even H., Dugo, Matteo, Devecchi, Andrea, De Cecco, Loris, Sensi, Marialuisa, Terragna, Carolina, Martello, Marina, Bagratuni, Tina, Kastritis, Efstathios, Dimopoulos, Meletios A., Cavo, Michele, Carniti, Cristiana, Montefusco, Vittorio, Corradini, Paolo, Bolli, Niccolo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Lymphoid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7065476/
https://ncbi.nlm.nih.gov/pubmed/32126144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000779
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak